Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tharimmune ( (THAR) ) has shared an update.
On September 5, 2025, Tharimmune, Inc. received confirmation from Nasdaq that it complies with Listing Rule 5550(b)(1) after reporting stockholders’ equity of $6,876,335 as of August 31, 2025. This compliance closes the matter with Nasdaq, potentially stabilizing the company’s market position and reassuring stakeholders.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,023,049
Technical Sentiment Signal: Buy
Current Market Cap: $23.53M
For detailed information about THAR stock, go to TipRanks’ Stock Analysis page.